To determine whether interleukin-20 receptors (IL-20R) are expressed in trabecular meshwork cells and the effect of a T104M mutation in IL-20R2 on downstream cellular functions.
Methods:
Evaluation of signal transducer and activator of transcription (STAT)3 phosphorylation and generic matrix metalloproteinase (MMP) activity in primary open angle glaucoma (POAG) dermal fibroblasts (pHDF) with the T104M IL-20R2 mutation were compared with normal human dermal fibroblasts (HDF). Expression of IL-20R1 and IL-20R2 in human trabecular meshwork (HTM) cells was determined by immunohistochemistry and western immunoblotting.
Results:
A T104M mutation in IL20-R2 was identified in a large POAG family in which the GLC1C locus was originally mapped. pHDFs harboring this mutation had significantly increased phosphorylated STAT3 (pSTAT3) activity compared with normal HDFs. However, stimulation with either IL-19 or IL-20 for 15 min resulted in significantly decreased levels of pSTAT3 in pHDFs compared with controls. Generic MMP activity was significantly decreased in pHDFs compared with controls after stimulation with IL-20 for 24 h. Both IL-20R1 and IL-20R2 receptors were expressed in HTM cells by western immunoblot and immunofluorescence, and they appeared to be up-regulated in response to cytokine treatment.
Conclusions:
A T104M mutation in IL-20R2 significantly impacts the function of this receptor as shown by decreased pSTAT3 levels and generic MMP activity. Reduced MMP activity may affect the ability of glaucoma patients to alter outflow resistance in response to elevated intraocular pressure.
Get full access to this article
View all access options for this article.
References
1.
VarmaR., LeeP.P., GoldbergI., and KotakS.An assessment of the health and economic burdens of glaucoma. Am. J. Ophthalmol., 152:515–522, 2011.
FanB.J., WangD.Y., LamD.S., and PangC.P.Gene mapping for primary open angle glaucoma. Clin. Biochem., 39:249–258, 2006.
4.
FanB.J., WangD.Y., PasqualeL.R., HainesJ.L., and WiggsJ.L.Genetic variants associated with optic nerve vertical cup-to-disc ratio are risk factors for primary open angle glaucoma in a US Caucasian population. Invest. Ophthalmol. Vis. Sci., 52:1788–1792, 2011.
5.
RamdasW.D., van KoolwijkL.M., IkramM.K., et al.A genome-wide association study of optic disc parameters. PLoS Genet., 6:e1000978, 2010.
6.
RamdasW.D., van KoolwijkL.M., LemijH.G., et al.Common genetic variants associated with open-angle glaucoma. Hum. Mol. Genet., 20:2464–2471, 2011.
7.
MacgregorS., HewittA.W., HysiP.G., et al.Genome-wide association identifies ATOH7 as a major gene determining human optic disc size. Hum. Mol. Genet., 19:2716–2724, 2010.
8.
BurdonK.P., MacgregorS., HewittA.W., et al.Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1. Nat. Genet., 43:574–578, 2011.
9.
ThorleifssonG., WaltersG.B., HewittA.W., et al.Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma. Nat. Genet., 42:906–909, 2010.
10.
VincentA.L., BillingsleyG., BuysY., et al.Digenic inheritance of early-onset glaucoma: CYP1B1, a potential modifier gene. Am. J. Hum. Genet., 70:448–460, 2002.
11.
MelkiR., ColombE., LefortN., BrezinA.P., and GarchonH.J.CYP1B1 mutations in French patients with early-onset primary open-angle glaucoma. J. Med. Genet., 41:647–651, 2004.
12.
ZhouX.M., YinY., FanN., et al.Single nucleotide polymorphism of MYOC affected the severity of primary open angle glaucoma. Int. J. Ophthalmol., 6:264–268, 2013.
13.
YoungT.K., SouzeauE., LiuL., et al.Compound heterozygote myocilin mutations in a pedigree with high prevalence of primary open-angle glaucoma. Mol. Vis., 18:3064–3069, 2012.
14.
RoseR., BalakrishnanA., MuthusamyK., ArumugamP., ShanmugamS., and GopalswamyJ.Myocilin mutations among POAG patients from two populations of Tamil Nadu, South India, a comparative analysis. Mol. Vis., 17:3243–3253, 2011.
15.
MochizukiH., MurphyC.J., BrandtJ.D., KiuchiY., and RussellP.Altered stability of mRNAs associated with glaucoma progression in human trabecular meshwork cells following oxidative stress. Invest. Ophthalmol. Vis. Sci., 53:1734–1741, 2012.
16.
GonzalezP., EpsteinD.L., and BorrasT.Genes upregulated in the human trabecular meshwork in response to elevated intraocular pressure. Invest. Ophthalmol. Vis. Sci., 41:352–361, 2000.
17.
JohnsonE.C., DoserT., CepurnaW.O., et al.Cell proliferation and interleukin-6 type cytokine signaling are implicated by gene expression responses in early optic nerve head injury in rat glaucoma. Invest. Ophthalmol. Vis. Sci., 52:504–518, 2011.
18.
LunaC., LiG., LitonP.B., EpsteinD.L., and GonzalezP.Alterations in gene expression induced by cyclic mechanical stress in trabecular meshwork cells. Mol. Vis., 15:534–544, 2009.
19.
PucciS., MazzarelliP., MissiroliF., RegineF., and RicciF.Neuroprotection: VEGF, IL-6, and clusterin: the dark side of the moon. Prog. Brain Res., 173:555–573, 2008.
20.
TripathiR.C., LiJ., ChanW.F., and TripathiB.J.Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2. Exp. Eye Res., 59:723–727, 1994.
21.
InataniM., TaniharaH., KatsutaH., HonjoM., KidoN., and HondaY.Transforming growth factor-beta 2 levels in aqueous humor of glaucomatous eyes. Graefes Arch. Clin. Exp. Ophthalmol., 239:109–113, 2001.
22.
KuchteyJ., RezaeiK.A., Jaru-AmpornpanP., SternbergP.Jr., and KuchteyR.W.Multiplex cytokine analysis reveals elevated concentration of interleukin-8 in glaucomatous aqueous humor. Invest. Ophthalmol. Vis. Sci., 51:6441–6447, 2010.
23.
TakaiY., TanitoM., and OhiraA.Multiplex cytokine analysis of aqueous humor in eyes with primary open-angle glaucoma, exfoliation glaucoma, and cataract. Invest. Ophthalmol. Vis. Sci., 53:241–247, 2012.
24.
ChuaJ., VaniaM., CheungC.M., et al.Expression profile of inflammatory cytokines in aqueous from glaucomatous eyes. Mol. Vis., 18:431–438, 2012.
25.
FreedmanJ., and IserovichP.Pro-inflammatory cytokines in glaucomatous aqueous and encysted molteno implant blebs and their relationship to pressure. Invest. Ophthalmol. Vis. Sci., 54:4851–4855, 2013.
26.
MenonR., IsmailL., IsmailD., MerialdiM., LombardiS.J., and FortunatoS.J.Human fetal membrane expression of IL-19 and IL-20 and its differential effect on inflammatory cytokine production. J. Matern. Fetal Neonatal Med., 19:209–214, 2006.
27.
ZhangB.F., LiuJ.J., PeiD.S., et al.Potent antitumor effect elicited by RGD-mda-7, an mda-7/IL-24 mutant, via targeting the integrin receptor of tumor cells. Cancer Biother. Radiopharm., 26:647–655.
28.
BlumbergH., ConklinD., XuW.F., et al.Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell., 104:9–19, 2001.
29.
DumoutierL., LeemansC., LejeuneD., KotenkoS.V., and RenauldJ.C.Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J. Immunol., 167:3545–3549, 2001.
30.
PletnevS., MagrachevaE., KozlovS., et al.Characterization of the recombinant extracellular domains of human interleukin-20 receptors and their complexes with interleukin-19 and interleukin-20. Biochemistry., 42:12617–12624, 2003.
31.
Parrish-NovakJ., XuW., BrenderT., et al.Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions. J. Biol. Chem., 277:47517–47523, 2002.
32.
SuZ.Z., MadireddiM.T., LinJ.J., et al.The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice. Proc. Natl. Acad. Sci. U. S. A., 95:14400–14405, 1998.
33.
SaekiT., MhashilkarA., ChadaS., BranchC., RothJ.A., and RameshR.Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitro. Gene Ther., 7:2051–2057, 2000.
34.
GallagherG., DickensheetsH., EskdaleJ., et al.Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes Immun., 1:442–450, 2000.
35.
ChangC., MagrachevaE., KozlovS., et al.Crystal structure of interleukin-19 defines a new subfamily of helical cytokines. J. Biol. Chem., 278:3308–3313, 2003.
36.
HsuY.H., HsingC.H., LiC.F., et al.Anti-IL-20 monoclonal antibody suppresses breast cancer progression and bone osteolysis in murine models. J. Immunol., 188:1981–1991, 2012.
37.
KellerK.E., AgaM., BradleyJ.M., KelleyM.J., and AcottT.S.Extracellular matrix turnover and outflow resistance. Exp. Eye Res., 88:676–682, 2009.
38.
PasuttoF., KellerK.E., WeisschuhN., et al.Variants in ASB10 are associated with open-angle glaucoma. Hum. Mol. Genet., 21:1336–1349, 2012.
39.
WirtzM.K., SamplesJ.R., KramerP.L., et al.Mapping a gene for adult-onset primary open-angle glaucoma to chromosome 3q. Am. J. Hum. Genet., 60:296–304, 1997.
40.
HitchingsR.A., and WheelerC.A.The optic disc in glaucoma. IV: Optic disc evaluation in the ocular hypertensive patient. Br. J. Ophthalmol., 64:232–239, 1980.
41.
PohjanpeltoP.E., and PalvaJ.Ocular hypertension and glaucomatous optic nerve damage. Acta Ophthalmol. (Copenh.), 52:194–200, 1974.
42.
PolanskyJ.R., WeinrebR.N., BaxterJ.D., and AlvaradoJ.Human trabecular cells. I. Establishment in tissue culture and growth characteristics. Invest. Ophthalmol. Vis. Sci., 18:1043–1049, 1979.
43.
RitchR., HargettN.A., PodosS.M., MardirossianJ., and KassM.A.Wrong drug dispensed. JAMA., 238:1628, 1977.
44.
StamerW.D., SeftorR.E., WilliamsS.K., SamahaH.A., and SnyderR.W.Isolation and culture of human trabecular meshwork cells by extracellular matrix digestion. Curr. Eye Res., 14:611–617, 1995.
45.
KellerK.E., YangY.F., SunY.Y., SykesR., AcottT.S., and WirtzM.K.Ankyrin repeat and suppressor of cytokine signaling box containing protein-10 is associated with ubiquitin-mediated degradation pathways in trabecular meshwork cells. Mol. Vis., 19:1639–1655, 2013.
46.
AgaM., BradleyJ.M., KellerK.E., KelleyM.J., and AcottT.S.Specialized podosome- or invadopodia-like structures (PILS) for focal trabecular meshwork extracellular matrix turnover. Invest. Ophthalmol. Vis. Sci., 49:5353–5365, 2008.
47.
KellerK.E., SunY.Y., VrankaJ.A., HayashiL., and AcottT.S.Inhibition of hyaluronan synthesis reduces versican and fibronectin levels in trabecular meshwork cells. PLoS One., 7:e48523, 2012.
48.
SamplesJ.R., KitsosG., Economou-PetersenE., et al.Refining the primary open-angle glaucoma GLC1C region on chromosome 3 by haplotype analysis. Clin. Genet., 65:40–44, 2004.
49.
LogsdonN.J., DeshpandeA., HarrisB.D., RajashankarK.R., and WalterM.R.Structural basis for receptor sharing and activation by interleukin-20 receptor-2 (IL-20R2) binding cytokines. Proc. Natl. Acad. Sci. U. S. A., 109:12704–12709, 2012.
50.
TsarevaS.A., MorigglR., CorvinusF.M., et al.Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction. Neoplasia., 9:279–291, 2007.
51.
SakaguchiM., OkaM., IwasakiT., FukamiY., and NishigoriC.Role and regulation of STAT3 phosphorylation at Ser727 in melanocytes and melanoma cells. J. Invest. Dermatol., 132:1877–1885, 2012.
52.
BradleyJ.M., KelleyM.J., ZhuX., AnderssohnA.M., AlexanderJ.P., and AcottT.S.Effects of mechanical stretching on trabecular matrix metalloproteinases. Invest. Ophthalmol. Vis. Sci., 42:1505–1513, 2001.
53.
BradleyJ.M., VrankaJ., ColvisC.M., et al.Effect of matrix metalloproteinases activity on outflow in perfused human organ culture. Invest. Ophthalmol. Vis. Sci., 39:2649–2658, 1998.
